Gadolinium → Gadobutrol (JAN/USAN/INN)

HRID 376486

Reaktionsgleichung

Reaktionsgleichung von HRID 376486
[Na+].[N:2]1([CH2:22][C:23]([O-:25])=[O:24])[CH2:13][CH2:12][NH:11][CH2:10][CH2:9][N:8]([CH2:14][C:15]([O-:17])=[O:16])[CH2:7][CH2:6][N:5]([CH2:18][C:19]([O-:21])=[O:20])[CH2:4][CH2:3]1.[Na+].[Na+].CC1(C)[O:36][CH2:35][CH:34]2[CH:32]([O:33]2)[CH2:31][O:30]1.[Gd:38]>>[CH2:4]1[N:5]([CH2:18][C:19]([O-:21])=[O:20])[CH2:6][CH2:7][N:8]([CH2:14][C:15]([O-:17])=[O:16])[CH2:9][CH2:10][N:11]([CH:34]([CH:32]([OH:33])[CH2:31][OH:30])[CH2:35][OH:36])[CH2:12][CH2:13][N:2]([CH2:22][C:23]([O-:25])=[O:24])[CH2:3]1.[Gd+3:38]

Komponenten

4

Versuchsvorschrift

The solution of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid sodium salt is directly reacted, as described in EP 448191, with 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane to give the alkylated product, which can, easily be complexed with gadolinium to give the final Gadobutrol.

Aufarbeitung

  1. customto give the alkylated product, which can,

Quellen und Nachweise

ORD-Eintrag
ord-b9f3472e03424b93b051e33c27e0e527
Quelldatensatz
uspto-grants-2000_02
Patentnummer
US06020485

Verknüpfte Notizen

Wird geladen…